Pharma

Aarti Drugs Ltd

AARTIDRUGS · NSE · INE767A01016
₹375.65+0.20%consolidatedstandalone
Monday, 26 Oct 2026Vol: 69.1K traded · 40.5% delivered11:46 am
Sentiment50 · Neutral
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹3,429 Cr
P/E18.2
P/B2.2
EPS₹20.68
Div Yield0.5%
ROE13.4%
ROCE11.2%
ROE13.4%
1Y Return+11.57%
Avg. Volume0.1M
Delivery %40.45%

Price Chart

5214704203703196.9L13.8LOct 2025Nov 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jul 2026Sept 2026

52-Week Range

₹318.95₹375.65₹534
52W Low52W High

About

Aarti Drugs Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹3,429 Cr
Current Price₹375.65
52W High / Low₹534 / ₹318.95
Stock P/E18.2
Price to Book2.2
EPS (TTM)₹20.68
Dividend Yield0.5%
ROE13.4%
1Y Return+11.57%
Day Change+0.20%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹2,678 Cr₹2,565 Cr₹2,387 Cr
Expenses₹2,344 Cr₹2,254 Cr₹2,097 Cr
Operating Profit₹333 Cr₹312 Cr₹290 Cr
OPM %12.0%12.0%12.0%
Other Income₹1 Cr₹2 Cr₹16 Cr
Depreciation₹71 Cr₹67 Cr₹56 Cr
Interest₹34 Cr₹36 Cr₹39 Cr
Profit Before Tax₹229 Cr₹211 Cr₹212 Cr
Tax₹38 Cr₹16 Cr₹44 Cr
Net Profit₹191 Cr₹195 Cr₹168 Cr
EPS (₹)21.021.418.4
Dividend Payout %—9%5%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹703 Cr₹720 Cr₹602 Cr₹653 Cr
Expenses₹605 Cr₹624 Cr₹547 Cr₹569 Cr
Operating Profit₹98 Cr₹96 Cr₹55 Cr₹84 Cr
OPM %14.0%13.0%9.0%13.0%
Depreciation₹18 Cr₹18 Cr₹18 Cr₹16 Cr
Interest₹9 Cr₹8 Cr₹9 Cr₹8 Cr
Net Profit₹50 Cr₹55 Cr₹41 Cr₹45 Cr
EPS (₹)5.56.14.45.0
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹91 Cr₹91 Cr₹92 Cr
Reserves₹1,458 Cr₹1,278 Cr₹1,190 Cr
Borrowings₹577 Cr₹615 Cr₹564 Cr
Other Liabilities₹689 Cr₹591 Cr₹586 Cr
Total Liabilities₹2,815 Cr₹2,575 Cr₹2,432 Cr
Assets
Fixed Assets₹1,086 Cr₹866 Cr₹811 Cr
Investments₹27 Cr₹22 Cr₹20 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹1,488 Cr₹1,356 Cr₹1,340 Cr
Total Assets₹2,815 Cr₹2,575 Cr₹2,432 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹254 Cr₹-173 Cr₹-77 Cr₹3 Cr
FY25₹245 Cr₹-165 Cr₹-82 Cr₹-2 Cr
FY24₹359 Cr₹-224 Cr₹-136 Cr₹-1 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd——+2.75%+59.84%
Aarti Pharmalabs Ltd——+8.51%+14.26%
Abbott India Ltd₹53,782 Cr33.6+34.46%-7.16%
Anlon Healthcare Ltd₹1,362 Cr37.7+18.65%+100.08%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-03Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE Filing2026-08-03Aarti Drugs Ltd (BOM:524348) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth and ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.